Tabernero Caturla, J., Grothey, A., Van Cutsem, E., Wasan, H., Yoshino, T., & Yaeger, R. (2021). Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study.
Citação norma ChicagoTabernero Caturla, Josep, Axel Grothey, Eric Van Cutsem, Harpreet Wasan, Takayuki Yoshino, y Rona Yaeger. Encorafenib Plus Cetuximab As a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses From the BEACON Study. 2021.
Citação norma MLATabernero Caturla, Josep, et al. Encorafenib Plus Cetuximab As a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses From the BEACON Study. 2021.